Topics

Biologics can be used effectively for both elderly-onset and young-onset RA patients

17:08 EST 10 Nov 2019 | News-Medical.net

According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, both patients with rheumatoid arthritis whose disease onset occurred at an older age and those whose disease onset occurred earlier in life have similar improvements in clinical disease at 48 weeks after starting biologic disease-modifying antirheumatic drugs, as well as similar drug maintenance and adverse events discontinuation rates.

Original Article: Biologics can be used effectively for both elderly-onset and young-onset RA patients

NEXT ARTICLE

More From BioPortfolio on "Biologics can be used effectively for both elderly-onset and young-onset RA patients"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...